September 29, 2026

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in Healthcare with a 1.56% Upside Potential

Pediatrix Medical Group, Inc. (MD) represents a pivotal player in the healthcare sector, specifically within the medical care facilities industry in the United States. As a provider of specialized newborn,..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 57% Potential Upside with Robust Analyst Ratings

Alphatec Holdings, Inc. (NASDAQ: ATEC), a leading player in the medical devices industry, particularly in spinal surgery technologies, presents an intriguing investment opportunity. With a current market capitalization of $1.55..

HUTCHMED (China) Limited (HCM) Stock Analysis: Unlocking a Potential 55.74% Upside with Strong Buy Ratings

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is crafting a compelling narrative for investors with its robust pipeline of targeted therapeutics and immunotherapies aimed at..

Mesoblast Limited (MESO): Unpacking the 155% Upside Potential in Regenerative Medicine

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, stands as a significant player in the healthcare sector with its pioneering work in regenerative medicine. With a market capitalization of $1.88..

National HealthCare Corporation (NHC) Stock Analysis: Navigating the Healthcare Giant’s Performance Metrics

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, operates within the medical care facilities industry, providing a wide range of services across the United States. With..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on a Biotech with 18% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), operating in the dynamic and ever-evolving biotechnology sector, has carved a niche for itself by focusing on therapies for rare neurological diseases. Headquartered in..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 15.4% Potential Upside in Medical Devices

Investors seeking opportunities in the healthcare sector might find LivaNova PLC (NASDAQ: LIVN) an intriguing prospect, particularly considering the company’s projected 15.4% potential upside. As a key player in the..

Kiniksa Pharmaceuticals (KNSA): Investor Outlook with 28.78% Potential Upside

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) stands out in the healthcare sector, particularly within the drug manufacturers – specialty & generic industry, as a company to watch closely. With a..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 95% Potential Upside in Biotech Innovation

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at the intersection of cutting-edge biotechnology and industrial-scale drug discovery, presenting a unique proposition for investors navigating the dynamic healthcare sector. With a market..

Ardent Health, Inc. (ARDT) Investor Outlook: Navigating the Potential 20.98% Upside

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers its services across the United States. With a market capitalization of..

Organon & Co. (OGN) Stock Analysis: Navigating Challenges with a Strong Return on Equity

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, focuses on women’s health solutions and a diverse range of prescription therapies. With a market capitalization of $3.61..

GRAIL, Inc. (GRAL) Investor Outlook: Navigating a 25.70% Revenue Growth in the Healthcare Sector

GRAIL, Inc. (NASDAQ: GRAL), a pioneering force in the healthcare sector, is making notable strides with its innovative approach to early cancer detection. As a commercial-stage company, GRAIL specializes in..

CONMED Corporation (CNMD) Stock Analysis: Navigating Potential in Medical Devices Amid Market Challenges

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector specializing in medical devices, presents a compelling case for investors, even amidst a challenging market environment. With a market..

ARS Pharmaceuticals, Inc. (SPRY): An Investor Outlook on Potential 444.79% Upside

Investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have been keeping a close eye on this innovative biopharmaceutical company, which is making significant strides in the healthcare sector. With a focus..

PACS Group, Inc. (PACS): An Investor’s Outlook on Healthcare’s Rising Star with a 37% Upside

PACS Group, Inc. (PACS), a prominent player in the healthcare sector specializing in medical care facilities, has been catching the eye of investors with its impressive growth trajectory and substantial..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 114.68% Potential Upside in Biotech Innovation

Investors eyeing opportunities in the biotechnology sector may find NewAmsterdam Pharma Company N.V. (NAMS) an intriguing proposition. With a market capitalization of $2.82 billion, this Netherlands-based biotech firm is making..

Phreesia, Inc. (PHR) Stock Analysis: Uncovering a 39.27% Upside Potential in Healthcare SaaS

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based platform aimed at revolutionizing patient engagement and administrative processes for healthcare providers. With a market..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 100% Upside Opportunity

For investors keeping a close eye on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing proposition. The company, headquartered in Hampton, New Jersey, specializes in developing therapeutic..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Promising 18.64% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, has captured investor attention with its innovative solutions in the medical devices industry. Headquartered in Newburyport, Massachusetts, UFPT’s..

Search

Funds

September 29, 2026

Search

Funds

September 29, 2026

FTSE 100

Funds